Peter G Maslak - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Peter G Maslak

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Blood|April 14, 2021

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.

Blood Advances|February 2, 2018

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.

Nature Medicine|May 21, 2021

CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.

Research Square|February 10, 2021

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Blood|April 14, 2021

Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.

Blood Advances|February 2, 2018

Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemiaPeter G Maslak, Tao Dao, Yvette Bernal, et al.

Nature Medicine|May 21, 2021

CD8<sup>+</sup> T cells contribute to survival in patients with COVID-19 and hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.

Research Square|February 10, 2021

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerErin M Bange, Nicholas A Han, Paul Wileyto, et al.

Pageof 2